NextCure (NXTC) Net Equity Issued and Repurchased (2019 - 2026)
NextCure (NXTC) posted quarterly Net Equity Issued and Repurchased of $1.2 million for Q1 2026, up 1858.73% quarter-over-quarter from $63000.0 in Q1 2021.
NextCure (NXTC) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends
NextCure's Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- In Q1 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.3 million (changed N/A YoY), while the FY2025 annual figure was $22.3 million, up 57017.95% from the prior year.
- Net Equity Issued and Repurchased for Q1 2026 stood at $1.2 million, up from $63000.0 in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $1.2 million in Q1 2026, with the low at $1.2 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | NextCure | 33.72 Mn | 33.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.23 Mn |
| Mar 31, 2026 | 1.23 Mn |
| Mar 31, 2021 | 63,000.00 |
| Mar 31, 2021 | 63,000.00 |
| Dec 31, 2020 | 18,000.00 |
| Dec 31, 2020 | 18,000.00 |
| Sep 30, 2020 | 54,000.00 |
| Sep 30, 2020 | 54,000.00 |
| Jun 30, 2020 | 3,000.00 |
| Jun 30, 2020 | 3,000.00 |
| Mar 31, 2020 | 37,000.00 |
| Mar 31, 2020 | 37,000.00 |
| Dec 31, 2019 | 54,000.00 |
| Dec 31, 2019 | 54,000.00 |
| Sep 30, 2019 | 22,000.00 |
| Sep 30, 2019 | 22,000.00 |
| Jun 30, 2019 | 39,000.00 |
| Jun 30, 2019 | 39,000.00 |
| Mar 31, 2019 | 4,000.00 |
| Mar 31, 2019 | 4,000.00 |